‘Pharma Bro’, who drove up anti-HIV drug costs by defrauding investors, gets imprison

The “Pharma Bro” was convicted last year to defraud financial specialists by demonstrating counterfeit record explanations of two failing hedge funds that he ran.

The main drug prices that were used to treat HIV was driven up 50 times by the Martin Shkreli, a previous drug firm executive has been condemned seven-year imprisonment by a New York government court for cheating investors.

The “Pharma Bro” was indicted a year ago to defraud investors by demonstrating counterfeit record explanations of two failing hedge funds that he ran.

As per the PBS reports, the 34-year-old pharmaceutical official, who had gained notoriety for driving up the cost of HIV medicine in 2015 and trolling commentators on the web, cried in the court and apologized to investors and said “I am terribly sorry I lost your trust,” he reportedly said in the court. “You deserve far better.

In spite of the fact that his lawyers requested for tolerance in condemning, the U.S. District Judge Kiyo Matsumoto termed his crimes seriously and handed him the sentence.

Related Posts

CDSCO releases MedTech Mitra’s handbook

New Delhi: The Central Drugs Standard Control Organisation (CDSCO), in collaboration with Indian Council of Medical Research (ICMR), has released the MedTech Mitra’s handbook for innovators in the in-vitro diagnostics…

Telangana Rising Vision Document Aims for USD 3 Trillion Economy

Hyderabad: Telangana Chief Minister A Revanth Reddy has introduced the Telangana Rising vision document, which aims to transform the state into a USD three trillion economy by 2047. This announcement…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO releases MedTech Mitra’s handbook

CDSCO releases MedTech Mitra’s handbook

Telangana Rising Vision Document Aims for USD 3 Trillion Economy

Telangana Rising Vision Document Aims for USD 3 Trillion Economy

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of Semaglutide

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of Semaglutide

Strides Pharma names Nandini Matiyani Global Head of HR

Strides Pharma names Nandini Matiyani Global Head of HR

Novo Nordisk now wants Sun Pharma to stop dealing in weight loss drug compound, goes to Delhi HC again

Novo Nordisk now wants Sun Pharma to stop dealing in weight loss drug compound, goes to Delhi HC again

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug